Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Biotechnology Value Fund L P’

Sergey Nivens/Shutterstock.com

13G Filing: Biotechnology Value Fund LP and Forward Pharma A/S (FWP)

Forward Pharma A/S (NASDAQ:FWP): Mark Lampert’s Biotechnology Value Fund LP filed an amended 13D. You can check out Biotechnology Value Fund LP&#......(read more)
Copyright: nexusplexus / 123RF Stock Photo

13G Filing: Biotechnology Value Fund LP and Erytech Pharma SA (ADR) (ERYP)

Erytech Pharma SA (ADR) (NASDAQ:ERYP): Mark Lampert’s Biotechnology Value Fund LP filed an amended 13D. You can check out Biotechnology Value Fund......(read more)
biotechnological

13G Filing: Biotechnology Value Fund LP and Glycomimetics Inc (GLYC)

Glycomimetics Inc (NASDAQ:GLYC): Mark Lampert’s Biotechnology Value Fund LP filed an amended 13D. You can check out Biotechnology Value Fund LP&#......(read more)
Easiest Md/PhD Programs to Get Into

13G Filing: Biotechnology Value Fund LP and Cytokinetics Inc (CYTK)

Cytokinetics Inc (NASDAQ:CYTK): Mark Lampert’s Biotechnology Value Fund LP filed an amended 13D. You can check out Biotechnology Value Fund LP&#......(read more)
pharmacist, worker, shelves, business, counter, glasses, attractive, medical, competence, chemist, adult, clinic, drugstore, selling, female, consultation, medicine, coat

13G Filing: Biotechnology Value Fund LP and Syndax Pharmaceuticals Inc (SNDX)

Syndax Pharmaceuticals Inc (NASDAQ:SNDX): Mark Lampert’s Biotechnology Value Fund LP filed an amended 13D. You can check out Biotechnology Value......(read more)
Easiest Md/PhD Programs to Get Into

13G Filing: Biotechnology Value Fund LP and Spero Therapeutics Inc (SPRO)

Spero Therapeutics Inc (NASDAQ:SPRO): Mark Lampert’s Biotechnology Value Fund LP filed an amended 13D. You can check out Biotechnology Value Fund......(read more)
biotechnological

13G Filing: Biotechnology Value Fund LP and Arqule Inc (ARQL)

Arqule Inc (NASDAQ:ARQL): Mark Lampert’s Biotechnology Value Fund LP filed an amended 13D. You can check out Biotechnology Value Fund LP’s......(read more)
Easiest Md/PhD Programs to Get Into

13G Filing: Biotechnology Value Fund L P and Arqule Inc (ARQL)

Arqule Inc (NASDAQ:ARQL): Mark Lampert’s Biotechnology Value Fund LP filed an amended 13D. You can check out Biotechnology Value Fund LP’......(read more)
Copyright: nexusplexus / 123RF Stock Photo

13G Filing: Biotechnology Value Fund LP and Spring Bank Pharmaceuticals Inc (SBPH)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 13 – SEC Filing  UNITED STATES SECURITIES AND EXCHANGE......(read more)
biotech research company, bio-technology companies

13D Filing: Biotechnology Value Fund LP and BioLineRX Ltd. (BLRX)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 15 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
biotech research company, bio-technology companies

13G Filing: Biotechnology Value Fund LP and Contrafect Corp (CFRX)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 13 – SEC Filing  UNITED STATES SECURITIES AND EXCHANGE......(read more)
biotechnological

13G Filing: Biotechnology Value Fund LP and Alpine Immune Sciences Inc. (ALPN)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 13 – SEC Filing  UNITED STATES SECURITIES AND EXCHANGE......(read more)
biotechnological

13G Filing: Biotechnology Value Fund LP and Regulus Therapeutics Inc. (RGLS)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 13 – SEC Filing  UNITED STATES SECURITIES AND EXCHANGE......(read more)
lab, laboratory, clinic, clinical, scientist, researching, research, chemist, medical, man, male, specialist, focus, chemistry, test, science

13G Filing: Biotechnology Value Fund LP and CytomX Therapeutics Inc (CTMX)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 13 – SEC Filing  UNITED STATES SECURITIES AND EXCHANGE......(read more)
biotechnological

13D Filing: Biotechnology Value Fund LP and CTI Biopharma Corp (CTIC)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 13 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
biotechnological

13G Filing: Biotechnology Value Fund LP and Oncomed Pharmaceuticals Inc (OMED)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 13 – SEC Filing  UNITED STATES SECURITIES AND EXCHANGE......(read more)
biotechnological

13G Filing: Biotechnology Value Fund LP and Regulus Therapeutics Inc. (RGLS)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 13 – SEC Filing  UNITED STATES SECURITIES AND EXCHANGE......(read more)
biotechnological

13G Filing: Biotechnology Value Fund LP and Blueprint Medicines Corp (BPMC)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 13 – SEC Filing  UNITED STATES SECURITIES AND EXCHANGE......(read more)
biotechnological

13G Filing: Biotechnology Value Fund LP and Oncomed Pharmaceuticals Inc (OMED)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 13 – SEC Filing  UNITED STATES SECURITIES AND EXCHANGE......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

Tobira Therapeutics Inc. (TBRA): BVF Slashes Its Stake to 2.1% Following Merger Announcement

Mark Lampert‘s Biotechnology Value Fund LP recently filed a 13G with the US SEC to report lowering its stake in Tobira Therapeutics Inc. (NASDAQ......(read more)
30 Funniest Science Jokes, Puns, and Humor Quotes Ever

Anthera Pharmaceuticals Inc (ANTH): Biotechnology Value Fund Reports 9.99% Stake

Mark Lampert‘s Biotechnology Value Fund recently filed a Form 13G with the SEC, in which it reported acquiring 4.58 million shares of Anthera Pharmaceuticals......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

Xenon Pharmaceuticals Inc. (XENE): Biotechnology Value Fund Adds More Shares

Mark Lampert‘s Biotechnology Value Fund reported raising its stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) to 3.11 million shares, which account......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Blueprint Medicines Corp (BPMC): Biotechnology Value Fund Reports 10.4% Stake

According to a recent 13G filing with the US Securities and Exchange Commission, Mark Lampert‘s Biotechnology Value Fund L. P. owns 2.84 million......(read more)
mri, doctor, physicians, display, treatment, idea, medic, experiment, pharmaceutical, patient, future, interface, laboratory, multimedia, intelligence, male, digital, scan,

Cytokinetics Inc (CYTK): Mark Lampert’s Biotechnology Value Fund Loads Up On More Shares

Mark Lampert‘s Biotechnology Value Fund has filed a Form 13G on Cytokinetics, Inc. (NASDAQ:CYTK), one of its top-10 holdings at the end of 2015......(read more)